Drugs such as liraglutide, semaglutide, dulaglutide, and the dual GLP-1/GIP receptor agonist tirzepatide demonstrate robust efficacy for weight reduction and glycemic optimization
The dataset analyzed in this manuscript is derived from a frozen snapshot of the UKBB data, encompassing all available samples up to 31 January 2024, totaling n = 502,536
Recently, MIC/L-Carnitine weight-loss has grown in popularity
Dispatch typically follows within one working day of a prescription being confirmed
Abdulwahid A-HRR, Mahdi MH, Amiri BS, Koosehlar E, Kazemi N, Ghiasi F, et al
A larger percentage of liver cancers in these cases occur before end-stage liver failure, and thus are less likely to be screened for, increasing the tendencies for liver tumors to be larger and more difficult to treat at the time they are diagnosed